Sorrento Therapeutics, Inc.Sorrento Therapeutics, Inc.Sorrento Therapeutics, Inc.

Sorrento Therapeutics, Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪6.01 M‬USD
‪542.56 M‬
Beta (1Y)
−14.46

About SORRENTO THERAPEUTICS INC

CEO
Henry H. Ji
Headquarters
San Diego
Founded
1989
Sorrento Therapeutics, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It operates through the Sorrento Therapeutics and Scilex segments. The Sorrento Therapeutics segment consists of developing a portfolio of next generation treatments for three major therapeutic areas: cancer, infectious disease, and pain. The Scilex segment is largely organized around the company's non-opioid pain management operations. The company was founded by Henry H. Ji in 1989 and is headquartered in San Diego, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of SRNEQ is 0.030000 USD — it has increased by 3.45% in the past 24 hours. Watch Sorrento Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Sorrento Therapeutics, Inc. stocks are traded under the ticker SRNEQ.
SRNEQ reached its all-time high on Feb 15, 2007 with the price of 750.000000 USD, and its all-time low was 0.001000 USD and was reached on Jan 30, 2024. View more price dynamics on SRNEQ chart.
See other stocks reaching their highest and lowest prices.
SRNEQ stock is 55.00% volatile and has beta coefficient of −14.46. Track Sorrento Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Sorrento Therapeutics, Inc. there?
Today Sorrento Therapeutics, Inc. has the market capitalization of ‪6.01 M‬, it has increased by 45.00% over the last week.
Yes, you can track Sorrento Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Sorrento Therapeutics, Inc. is going to release the next earnings report on Aug 13, 2024. Keep track of upcoming events with our Earnings Calendar.
No, SRNEQ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, SRNEQ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Sorrento Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Sorrento Therapeutics, Inc. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Sorrento Therapeutics, Inc. stock shows the sell signal. See more of Sorrento Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.